BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 21412821)

  • 1. Perceptions of "urgency" in women with interstitial cystitis/bladder pain syndrome or overactive bladder.
    Clemens JQ; Bogart LM; Liu K; Pham C; Suttorp M; Berry SH
    Neurourol Urodyn; 2011 Mar; 30(3):402-5. PubMed ID: 21412821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
    Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
    BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of bladder pressure and discomfort symptoms: How do overactive bladder differ from interstitial cystitis/bladder pain syndrome patients?
    Gousse A; Vetter J; Lai HH
    BMC Urol; 2023 Mar; 23(1):53. PubMed ID: 36997906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Overactive Bladder Symptoms Among Women With Interstitial Cystitis/Bladder Pain Syndrome.
    Dubinskaya A; Tholemeier LN; Erickson T; De Hoedt AM; Barbour KE; Kim J; Freedland SJ; Anger JT
    Female Pelvic Med Reconstr Surg; 2022 Mar; 28(3):e115-e119. PubMed ID: 35272344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction.
    Ackerman AL; Jackson NJ; Caron AT; Kaufman MR; Routh JC; Lowder JL
    medRxiv; 2023 Apr; ():. PubMed ID: 37131628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urgency and pain in patients with overactive bladder and bladder pain syndrome. What are the differences?
    Castro-Diaz D; Cardozo L; Chapple CR; Espuña M; Kelleher C; Kirby M; Milsom I; Sievert KD; Tubaro A
    Int J Clin Pract; 2014 Mar; 68(3):356-62. PubMed ID: 24373133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Urodynamic Parameters Between Women With Interstitial Cystitis and/or Bladder Pain Syndrome and Severe Overactive Bladder.
    Shim JS; Kang SG; Park JY; Bae JH; Kang SH; Park HS; Moon du G; Cheon J; Lee JG; Kim JJ; Oh MM
    Urology; 2016 Aug; 94():64-9. PubMed ID: 27130264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology, assessment, and treatment of overactive bladder symptoms in patients with interstitial cystitis/bladder pain syndrome.
    Dobberfuhl AD
    Neurourol Urodyn; 2022 Nov; 41(8):1958-1966. PubMed ID: 35607890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis.
    Lai HH; Vetter J; Jain S; Gereau RW; Andriole GL
    J Urol; 2014 Dec; 192(6):1679-85. PubMed ID: 24907443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Childhood Experiences in Women With Overactive Bladder or Interstitial Cystitis/Bladder Pain Syndrome.
    Komesu YM; Petersen TR; Krantz TE; Ninivaggio CS; Jeppson PC; Meriwether KV; Dunivan GC
    Female Pelvic Med Reconstr Surg; 2021 Jan; 27(1):e208-e214. PubMed ID: 33369968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary nerve growth factor correlates with the severity of urgency and pain.
    Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH
    Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of life and related factors in patients with interstitial cystitis/bladder pain syndrome].
    Wang JW; Liu JC; Meng LF; Zhang W; Liu XD; Zhang YG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):653-658. PubMed ID: 34393223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Severity and Distribution of Nonurologic Pain and Urogenital Pain in Overactive Bladder are Intermediate Between Interstitial Cystitis and Controls.
    Thu JHL; Vetter J; Lai HH
    Urology; 2019 Aug; 130():59-64. PubMed ID: 31034917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome.
    Ke H; Zhu L; Wang Q; Xu K
    BMC Urol; 2023 Nov; 23(1):180. PubMed ID: 37940904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome.
    Mu HY; Wu MP; Wang IT; Wu JC; Chin HY
    Medicine (Baltimore); 2023 Feb; 102(6):e32790. PubMed ID: 36820564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
    Kuo YC; Kuo HC
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential factors that can be used to differentiate between interstitial cystitis/painful bladder syndrome and bladder oversensitivity in women.
    Kuo YC; Kuo HC
    Int J Clin Pract; 2012 Feb; 66(2):146-51. PubMed ID: 21951755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An urgent case for sensory urgency: A patient perspective.
    Meijlink J
    Neurourol Urodyn; 2020 Sep; 39(7):2008-2010. PubMed ID: 32648972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score.
    Humphrey L; Arbuckle R; Moldwin R; Nordling J; van de Merwe JP; Meunier J; Crook T; Abraham L
    Eur Urol; 2012 Feb; 61(2):271-9. PubMed ID: 22050826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.